RHOA and breast cancer: Given the fact that overexpression of RhoA and VEGF-VEGFR2 is contributed to poor prognosis in malignancies [13, 22, 27] and evidence for linking protein intake and BC risk is often rare in epidemiologic studies [5], there is a need to investigate the nutrigenomic aspect of angiogenesis in a population of BC patients.